Novelix Pharmaceuticals (BOM:536565) Margin of Safety % (DCF Earnings Based): N/A (As of Jul. 04, 2026)


BOM:536565 Novelix Pharmaceuticals Ltd BOM:536565
68 GF Score
Price ₹77.97
GF Value ₹144.17
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is Novelix Pharmaceuticals Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Novelix Pharmaceuticals's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

BOM:536565 vs MCK, CAH, COR: Margin of Safety % (DCF Earnings Based) Comparison

For the Medical Distribution subindustry, Novelix Pharmaceuticals's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novelix Pharmaceuticals Margin of Safety % (DCF Earnings Based) vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Novelix Pharmaceuticals's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Novelix Pharmaceuticals's Margin of Safety % (DCF Earnings Based) falls into.


BOM:536565
68GF Score
Novelix Pharmaceuticals Ltd BOM:536565
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Novelix Pharmaceuticals (BOM:536565) Overvalued in 2026?

Based on GuruFocus' analysis, Novelix Pharmaceuticals stock appears to be undervalued. The current stock price of ₹77.97 is trading 45.9% below its estimated GF Value™ of ₹144.17. GuruFocus considers Novelix Pharmaceuticals to be Possible Value Trap.

Key valuation signals for BOM:536565:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ₹144.17 vs. price of ₹77.97 (45.9% below fair value)
  • GF Score™: 68/100 with 8 warning signs

No single metric tells the full story. See the BOM:536565 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Novelix Pharmaceuticals Business Description

Address Lingapur LA Builders, Amrutha Estates, 6th floor, House no. 3-6-237/610, Himayath nagar, Hyderabad, TG, IND, 500029
Novelix Pharmaceuticals Ltd is into the business of Trading of Pharmaceuticals and related products and is into the business of trading of shares and securities. The company generates majaority of its revenue from the Pharmaceuticals business.
68GF Score

Get the complete analysis for BOM:536565

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹77.97
Price
₹144.17
GF Value